5-162067625-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The ENST00000639111.2(GABRG2):c.-375G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000441 in 496,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
GABRG2
ENST00000639111.2 5_prime_UTR
ENST00000639111.2 5_prime_UTR
Scores
6
Clinical Significance
Conservation
PhyloP100: 1.59
Genes affected
GABRG2 (HGNC:4087): (gamma-aminobutyric acid type A receptor subunit gamma2) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammlian brain, where it acts at GABA-A receptors, which are ligand-gated chloride channels. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene have been associated with epilepsy and febrile seizures. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.026697993).
BP6
?
Variant 5-162067625-G-C is Benign according to our data. Variant chr5-162067625-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2571239.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00107 (163/152128) while in subpopulation AFR AF= 0.00357 (148/41512). AF 95% confidence interval is 0.0031. There are 0 homozygotes in gnomad4. There are 84 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
?
High AC in GnomAd at 163 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GABRG2 | NM_001375347.1 | c.4G>C | p.Asp2His | missense_variant | 1/10 | ||
GABRG2 | NM_001375339.1 | c.-375G>C | 5_prime_UTR_variant | 1/10 | |||
GABRG2 | NM_001375340.1 | c.-375G>C | 5_prime_UTR_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GABRG2 | ENST00000639111.2 | c.-375G>C | 5_prime_UTR_variant | 1/9 | 1 | P3 | |||
GABRG2 | ENST00000640985.1 | c.4G>C | p.Asp2His | missense_variant | 1/10 | 5 | |||
GABRG2 | ENST00000639384.1 | c.-375G>C | 5_prime_UTR_variant | 1/9 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.00107 AC: 163AN: 152010Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
163
AN:
152010
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000163 AC: 56AN: 344474Hom.: 0 Cov.: 0 AF XY: 0.000147 AC XY: 26AN XY: 176646
GnomAD4 exome
AF:
AC:
56
AN:
344474
Hom.:
Cov.:
0
AF XY:
AC XY:
26
AN XY:
176646
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00107 AC: 163AN: 152128Hom.: 0 Cov.: 31 AF XY: 0.00113 AC XY: 84AN XY: 74350
GnomAD4 genome
?
AF:
AC:
163
AN:
152128
Hom.:
Cov.:
31
AF XY:
AC XY:
84
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2023 | GABRG2: BS1 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
MutationTaster
Benign
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at